These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31515354)

  • 21. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
    Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.
    Li S; Chen L; Jin W; Ma X; Ma Y; Dong F; Zhu H; Li J; Wang K
    Sci Rep; 2017 Dec; 7(1):17998. PubMed ID: 29269861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
    Chillón MC; Santamaría C; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Marín L; Caballero MD; Vidriales MB; Ramos F; Bernal T; Díaz-Mediavilla J; García de Coca A; Peñarrubia MJ; Queizán JA; Giraldo P; San Miguel JF; González M
    Haematologica; 2010 May; 95(5):745-51. PubMed ID: 20133893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.
    Kutny MA; Moser BK; Laumann K; Feusner JH; Gamis A; Gregory J; Larson RA; Powell BL; Stock W; Willman CL; Woods WG; Meshinchi S
    Pediatr Blood Cancer; 2012 Oct; 59(4):662-7. PubMed ID: 22378655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status.
    Marasca R; Maffei R; Zucchini P; Castelli I; Saviola A; Martinelli S; Ferrari A; Fontana M; Ravanetti S; Torelli G
    Leukemia; 2006 Jan; 20(1):103-14. PubMed ID: 16270043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review.
    Beitinjaneh A; Jang S; Roukoz H; Majhail NS
    Leuk Res; 2010 Jul; 34(7):831-6. PubMed ID: 20096459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
    Gale RE; Hills R; Pizzey AR; Kottaridis PD; Swirsky D; Gilkes AF; Nugent E; Mills KI; Wheatley K; Solomon E; Burnett AK; Linch DC; Grimwade D;
    Blood; 2005 Dec; 106(12):3768-76. PubMed ID: 16105978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myeloid leukemia with NPM1 and FLT3 ITD mimicking acute promyelocytic leukemia.
    Pepper M; Tan B
    Blood; 2020 Sep; 136(12):1467. PubMed ID: 32941638
    [No Abstract]   [Full Text] [Related]  

  • 29. PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.
    Cicconi L; Divona M; Ciardi C; Ottone T; Ferrantini A; Lavorgna S; Alfonso V; Paoloni F; Piciocchi A; Avvisati G; Ferrara F; Di Bona E; Albano F; Breccia M; Cerqui E; Sborgia M; Kropp MG; Santoro A; Levis A; Sica S; Amadori S; Voso MT; Mandelli F; Lo-Coco F
    Leukemia; 2016 Oct; 30(10):1987-1992. PubMed ID: 27133819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes.
    Albouhair S; Morgado E; Lavau C
    PLoS One; 2013; 8(8):e72261. PubMed ID: 23977266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen.
    Mathews V; Thomas M; Srivastava VM; George B; Srivastava A; Chandy M
    Haematologica; 2007 Jul; 92(7):994-5. PubMed ID: 17606455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
    Cloos J; Goemans BF; Hess CJ; van Oostveen JW; Waisfisz Q; Corthals S; de Lange D; Boeckx N; Hählen K; Reinhardt D; Creutzig U; Schuurhuis GJ; Zwaan ChM; Kaspers GJ
    Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [FLT3-ITD Mutation in Newly Diagnosed Patients with Acute Promyelocytic Leukemia].
    Gong BF; Wang Y; Lin D; Wei H; Li W; Zhou CL; Liu BC; Liu KQ; Zhang GJ; Liu YT; Li Y; Wei SN; Gong XY; Zhao XL; Qiu SW; Gu RX; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1615-1621. PubMed ID: 28024465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FLT3-ITD Mutations in Egyptian Patients of Acute Myeloid Leukemia: Correlation with Cytogenetic, FAB Subgroups and Prognosis.
    Adnan-Awad S; Gaber O; Eltokhy SA; Mourad D; Amer M; Kandeel EZ; Eldesouky I
    Clin Lab; 2017 May; 63(5):1027-1034. PubMed ID: 28627830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis for the potential application of FLT3-TKD mutations as prognostic indicator in non-promyelocytic AML.
    Li W; Zhang L; Huang L; Mi Y; Wang J
    Leuk Res; 2012 Feb; 36(2):186-91. PubMed ID: 21907407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arsenic: The gold standard for acute promyelocytic leukaemia with FLT3-ITD mutation].
    Esnault C; Rahmé R; de Thé H
    Med Sci (Paris); 2021 May; 37(5):544-546. PubMed ID: 34003103
    [No Abstract]   [Full Text] [Related]  

  • 37. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCB6 RNA expression in leukemias--expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia.
    Abraham A; Karathedath S; Varatharajan S; Markose P; Chendamarai E; Jayavelu AK; George B; Srivastava A; Mathews V; Balasubramanian P
    Ann Hematol; 2014 Mar; 93(3):509-12. PubMed ID: 23793916
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Testa U; Lo-Coco F
    Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [FLT3 internal tandem duplication in patients with acute promyelocytic leukemia].
    Zhu YM; Liu YF; Zhang SJ; Shen ZX; Hu J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):371-4. PubMed ID: 17939400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.